Micro cap research
Select micro cap research reports on companies we feel have the potential for success in resources, medtech and more.
May 2024
Control Bionics
Medtech Micro Cap
Control Bionics Limited (ASX: CBL) is an Australian medical device company specialising in innovative electromyography (EMG) solutions for assistive communication, mobility, and data measurement. Since its IPO in December 2020, the company has prioritised expanding its core business, which continues to grow organically. However, recent innovations have opened new avenues for growth.
With its extensive experience in commercialisation, patented world- class technology, and regulatory approvals across multiple jurisdictions, including the US, CBL is primed for expanded global reach. Bolstered by a strong pipeline of new products and diverse growth prospects, Lynx Advisors views CBL as an attractive investment opportunity.
february 2024
Aguia Resources
Resources Micro Cap (Gold)
Aguia Resources (ASX:AGR) is a multi-commodity exploration company with well-advanced and 100% owned organic phosphate and copper projects in Brazil. Both projects contain sizeable resources with favourable economics with the potential to deliver strong future shareholder returns.
To complement these projects, AGR has proposed to acquire Andean Mining in an off-market takeover bid expected to be completed in March 2024. Andean has a portfolio of gold, copper, and silver assets in Colombia across three projects.
Lynx Advisors believes the acquisition of Andean will be transformational for Aguia shareholders as the potential near-term free cash flows from the flagship Santa Barbara Project can help AGR further develop this project and others within its portfolio.
sign up